| The international WAO/EAACI guideline for the management of hereditary angioedema–the 2017 revision and update M Maurer, M Magerl, I Ansotegui, E Aygören-Pürsün, S Betschel, K Bork, ... World Allergy Organization Journal 11, 1-20, 2018 | 879* | 2018 |
| 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema T Bowen, M Cicardi, H Farkas, K Bork, HJ Longhurst, B Zuraw, ... Allergy, Asthma & Clinical Immunology 6, 1-13, 2010 | 648 | 2010 |
| Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema M Cicardi, A Banerji, F Bracho, A Malbrán, B Rosenkranz, M Riedl, K Bork, ... New England Journal of Medicine 363 (6), 532-541, 2010 | 640 | 2010 |
| Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group M Cicardi, K Bork, T Caballero, T Craig, HH Li, H Longhurst, A Reshef, ... Allergy 67 (2), 147-157, 2012 | 449 | 2012 |
| Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks TJ Craig, RJ Levy, RL Wasserman, AK Bewtra, D Hurewitz, K Obtułowicz, ... Journal of Allergy and Clinical Immunology 124 (4), 801-808, 2009 | 403 | 2009 |
| Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial WR Lumry, HH Li, RJ Levy, PC Potter, H Farkas, D Moldovan, M Riedl, ... Annals of Allergy, Asthma & Immunology 107 (6), 529-537. e2, 2011 | 245 | 2011 |
| Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor H Longhurst, M Cicardi, T Craig, K Bork, C Grattan, J Baker, HH Li, ... New England journal of medicine 376 (12), 1131-1140, 2017 | 235 | 2017 |
| International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency H Farkas, I Martinez‐Saguer, K Bork, T Bowen, T Craig, M Frank, ... Allergy 72 (2), 300-313, 2017 | 214 | 2017 |
| Immunoglobulin E antibody reactivity to the major shrimp allergen, tropomyosin, in unexposed Orthodox Jews J Fernandes, A Reshef, L Patton, R Ayuso, G Reese, SB Lehrer Clinical & Experimental Allergy 33 (7), 956-961, 2003 | 212 | 2003 |
| HAE international home therapy consensus document HJ Longhurst, H Farkas, T Craig, E Aygören-Pürsün, C Bethune, ... Allergy, Asthma & Clinical Immunology 6, 1-7, 2010 | 201 | 2010 |
| Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting A Zanichelli, HJ Longhurst, M Maurer, L Bouillet, W Aberer, V Fabien, ... Annals of Allergy, Asthma & Immunology 117 (4), 394-398, 2016 | 102 | 2016 |
| Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial MA Riedl, JA Bernstein, H Li, A Reshef, W Lumry, D Moldovan, H Farkas, ... Annals of Allergy, Asthma & Immunology 112 (2), 163-169. e1, 2014 | 91 | 2014 |
| Elevated D‐dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk A Reshef, A Zanichelli, H Longhurst, A Relan, CE Hack Allergy 70 (5), 506-513, 2015 | 81 | 2015 |
| Long-term outcomes with subcutaneous C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks T Craig, B Zuraw, H Longhurst, M Cicardi, K Bork, C Grattan, C Katelaris, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (6), 1793-1802. e2, 2019 | 78 | 2019 |
| The Hypereosinophilic Syndrome Associated with CD4+CD3″ Helper Type 2 (Th2) Lymphocytes I Bank, N Amariglio, A Reshef, I Hardan, Y Confino, H Trau, S Shtrasburg, ... Leukemia & lymphoma 42 (1-2), 123-133, 2001 | 76 | 2001 |
| Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial MA Riedl, V Grivcheva-Panovska, D Moldovan, J Baker, WH Yang, ... The Lancet 390 (10102), 1595-1602, 2017 | 72 | 2017 |
| The story of angioedema: from Quincke to bradykinin A Reshef, M Kidon, I Leibovich Clinical reviews in allergy & immunology 51, 121-139, 2016 | 68 | 2016 |
| International consensus on the use of genetics in the management of hereditary angioedema AE Germenis, M Margaglione, JB Pesquero, H Farkas, S Cichon, D Csuka, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (3), 901-911, 2020 | 67 | 2020 |
| Efficacy and safety of recombinant human C1‐inhibitor for the treatment of attacks of hereditary angioedema: European open‐label extension study D Moldovan, A Reshef, J Fabiani, S Kivity, E Toubi, M Shlesinger, ... Clinical & Experimental Allergy 42 (6), 929-935, 2012 | 67 | 2012 |
| Angiotensin-converting enzyme inhibitor–induced angioedema in a community hospital emergency department HM Bluestein, TA Hoover, AS Banerji, CA Camargo Jr, A Reshef, ... Annals of Allergy, Asthma & Immunology 103 (6), 502-507, 2009 | 67 | 2009 |
